Logo

regulatory guidance

FDA Issues New Guidance on SARS-CoV-2 Variants for Test Developers

The agency cautioned test companies that the presence of mutations in the virus could lead to false negative results.

FDA Issues Alert About Potential False Negative Test Results From SARS-CoV-2 Mutations

The agency identified three tests potentially impacted by known mutations, and said it will continue to monitor authorized assays.

SARS-CoV-2 Mutations Present Unexpected Opportunities, Challenges for MDx Developers
Premium

Some tests that detect multiple SARS-CoV-2 genes are serendipitously signaling new viral variants while still effectively detecting infections.

FDA Relaxes Rules for Flu, RSV Molecular Tests During Coronavirus Health Emergency

The new guidance allows developers to use other transport media and sample types without first obtaining 510(k) clearance.

FDA Will No Longer Review EUA Submissions for SARS-CoV-2 Lab-Developed Tests

The agency provided the update on Wednesday in its weekly virtual town hall and on its FAQ page.

Sep 3, 2020

International Commission Deems Germline Genome Editing Not Yet Safe in Human Embryos
Premium

Aug 28, 2020

Stakeholders Scramble to Predict Impact of HHS Move Limiting FDA Ability to Regulate LDTs
Premium

Jul 30, 2020

FDA Issues New Guidance for Non-Laboratory SARS-CoV-2 Diagnostic Tests, Pooled Testing

Jul 7, 2020

FDA Issues New Guidance for SARS-CoV-2 Pooled Sample Testing

Jun 19, 2020

Improved Pool Testing Methods Could Enable COVID-19 Screening as Pandemic Continues
Premium

Jun 17, 2020

FDA Provides Guidance on Pooled Samples, Asymptomatic Testing for SARS-CoV-2

May 29, 2020

FDA Adds At-Home Self-Collection Template to SARS-CoV-2 Emergency Use Authorization Guidance

May 14, 2020

FDA Requiring Real Patient Samples for Emergency Use Authorization of COVID-19 MDx Tests

Apr 13, 2020

FDA Releases Guidance Outlining Considerations for CDx Labeling for Oncology Drug Groups

Mar 26, 2020

FDA Fleshes Out Emergency Guidance for Coronavirus Test Developers

Mar 20, 2020

Commercial Coronavirus Test Developers Tweak Timelines, EUA Plans in Light of Loosened FDA Guidance

Mar 17, 2020

FDA Dramatically Expands Enforcement Discretion to Speed COVID-19 Test Access

Mar 16, 2020

Coronavirus Testing Delays Yield New Oversight Bill, Shine Light on LDT Regulation Debate

Mar 5, 2020

Coronavirus Dx Emergency Use Authorizations Progressing Rapidly Despite Criticism

Mar 3, 2020

Integrated DNA Technologies Authorized Under CDC EUA to Provide SARS-CoV-2 Test Kits

Oct 24, 2019

All of Us Program Working on IDE Submission to FDA, Weighing Long-Read Sequencing Techs
Premium

Jul 19, 2019

FDA Offers Guidance on Submitting NGS Data in Support of Antiviral Drugs

Mar 1, 2019

'Information Blocking' Plan Seeks to Free Data for Precision Medicine
Premium

Dec 21, 2018

As Dog Genetic Testing Booms, Calls for Regulation Grow Louder
Premium

Dec 19, 2018

FDA CDx Class Labeling Draft Guidance May Ease Patient Access, Spur Competition Among Test Makers
Premium

Breaking News
The Scan

Science Papers Examine State of Human Genomic Research, Single-Cell Protein Quantification

In Science this week: a number of editorials and policy reports discuss advances in in human genomic research, and more.

Booster for At-Risk

The New York Times reports that the US Food and Drug Administration has authorized a third dose of the Pfizer-BioNTech SARS-CoV-2 vaccine for people 65 and older or at increased risk.

Preprints OK to Mention Again

Nature News reports the Australian Research Council has changed its new policy and now allows preprints to be cited in grant applications.

Hundreds of Millions More to Share

The US plans to purchase and donate 500 million additional SARS-CoV-2 vaccine doses, according to the Washington Post.